Magenta Therapeutics, Inc.

MGTA · NASDAQ
Analyze with AI
12/31/2024
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$85-$76-$71-$75
Dep. & Amort.$0$2$2$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$13$7$10$10
Change in WC$0-$3-$2-$1
Other Non-Cash-$7$3$1$0
Operating Cash Flow-$78-$67-$60-$64
Investing Activities
PP&E Inv.-$0-$0-$1-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$414-$69-$45-$96
Inv. Sales/Matur.$127$60$90$86
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$287-$10$43-$11
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$39$3$0$65
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$256$3$90$68
Financing Cash Flow$256$3$90$68
Forex Effect$0$0$0$0
Net Chg. in Cash-$109-$74$73-$7
Supplemental Information
Beg. Cash$132$133$60$67
End Cash$23$59$133$60
Free Cash Flow-$78-$67-$61-$64
Magenta Therapeutics, Inc. (MGTA) Financial Statements & Key Stats | AlphaPilot